Research Article: Pyroptosis and Inflammasome-Related Genes-NLRP, NLRC and NLRP Polymorphisms Were Associated with Risk of Lung Cancer
Abstract:
Lung cancer is the most common malignant tumor in China, and its incidence and mortality rank first among all tumors. Most patients with lung cancer were at an advanced stage by the time they noticed the symptoms of the disease. Currently, lung cancer is treated mainly with surgical resection, radiotherapy, and chemotherapy, adjuvant to emerging molecular targeted therapy. Although treatment has improved significantly, survival rates for most advanced cancer patients are still difficult to improve. According to statistics, only % of lung cancer patients survive years after diagnosis. Therefore, it is important to strengthen basic research in the field of lung cancer and find specific immune markers for improving the survival rate of the patients. Single nucleotide polymorphisms (SNPs) genotyping has the characteristics of being simple, quick, and efficient, making it a promising method for identification of high-risk populations and avoiding the onset of the disease to the maximum extent.
Introduction:
Lung cancer is the most common malignant tumor in China, and its incidence and mortality rank first among all tumors. Most patients with lung cancer were at an advanced stage by the time they noticed the symptoms of the disease. Currently, lung cancer is treated mainly with surgical resection, radiotherapy, and chemotherapy, adjuvant to emerging molecular targeted therapy. Although treatment has improved significantly, survival rates for most advanced cancer patients are still difficult to improve. According to…
Read more